Колин Кэмпбелл - Китайское исследование: обновленное и расширенное издание. Классическая книга о здоровом питании [litres]
![Колин Кэмпбелл - Китайское исследование: обновленное и расширенное издание. Классическая книга о здоровом питании [litres]](/books/1059662/kolin-kempbell-kitajskoe-issledovanie-obnovlennoe.webp "Обложка книги")
- Название:Китайское исследование: обновленное и расширенное издание. Классическая книга о здоровом питании [litres]
- Автор:
- Жанр:
- Издательство:Литагент МИФ без БК
- Год:2018
- Город:Москва
- ISBN:978-5-00100-976-4
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Колин Кэмпбелл - Китайское исследование: обновленное и расширенное издание. Классическая книга о здоровом питании [litres] краткое содержание
На русском языке публикуется впервые.
Китайское исследование: обновленное и расширенное издание. Классическая книга о здоровом питании [litres] - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
300
С учетом возраста (от 25 до 74 лет).
301
Национальный институт болезней сердца, легких и крови США / National Heart, Lung, and Blood Institute. “Morbidity and Mortality: 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases.” Bethesda, MD: National Institutes of Health, 2002.
302
Mentias A., Barakat A., Raza M., et al. “An alarming trend: change in risk profile of patients with ST elevation myocardial infarction over the last two decades.” J. Am. Coll. Cardiol. 67 (2016): 659.
303
Marwick C. “Coronary bypass grafting economics, including rehabilitation. Commentary.” Curr. Opin. Cardiol. 9 (1994): 635–640.
304
С. 1319 в работе: Gersh B. J., Braunwald E., and Rutherford J. D. “Chronic coronary artery disease.” В: E. Braunwald (ed.), Heart Disease: A Textbook of Cardiovascular Medicine, Vol. 2 (5-е издание), 1289–1365. Philadelphia: W. B. Saunders, 1997.
305
Ornish D. “Avoiding revascularization with lifestyle changes: the Multicenter Lifestyle Demonstration Project.” Am. J. Cardiol. 82 (1998): 72T–76T.
306
Roger V. L., et al. “Heart disease and stroke statistics – 2011 update: a report from the American Heart Association.” Circulation 123 (2011): e18–e20.
307
Shaw P. J., Bates D., Cartlidge N. E. F., et al. “Early intellectual dysfunction following coronary bypass surgery.” Quarterly J. Med. 58 (1986): 59–68.
308
Cameron A. A. C., Davis K. B., and Rogers W. J. “Recurrence of angina after coronary artery bypass surgery. Predictors and prognosis (CASS registry).” J. Am. Coll. Cardiol. 26 (1995): 895–899.
309
С. 1320 в работе: Gersh B. J., Braunwald E., and Rutherford J. D. “Chronic coronary artery disease.” В: E. Braunwald (ed.), Heart Disease: A Textbook of Cardiovascular Medicine, Vol. 2 (5-е издание), 1289–1365. Philadelphia: W. B. Saunders, 1997.
310
Kirklin J. W., Naftel D. C., Blackstone E. H., et al. “Summary of a consensus concerning death and ischemic events after coronary artery bypass grafting.” Circulation 79 (Приложение 1) (1989): I81–I91.
311
Forrester J. S., and Shah P. K. “Lipid lowering versus revascularization: an idea whose time (for testing) has come.” Circulation 96 (1997): 1360–1362.
312
Forrester J. S., and Shah P. K. “Lipid lowering versus revascularization: an idea whose time (for testing) has come.” Circulation 96 (1997): 1360–1362.
313
Waldman P., Armstrong D., and Freedberg S. P. “Deaths linked to cardiac stents rise as overuse seen.” Bloomberg (26 сентября 2013). На сайте www.bloomberg.com/news/articles/2013–09–26/deaths-linked-to-cardiac-stents-rise-as-overuse-seen.
314
Garg S., Serruys P. W. “Coronary stents: current status.” J. Am. Coll. Cardiol. 56 (2010): S1–S42.
315
Stergiopoulos K., Brown D. L. “Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.” Arch. Intern. Med. 172 (2012): 312–319.
316
Waldman P., Armstrong D., and Freedberg S. P. “Deaths linked to cardiac stents rise as overuse seen.” Bloomberg (26 сентября 2013 г.). На сайте www.bloomberg.com/news/articles/2013–09–26/deaths-linked-to-cardiac-stents-rise-as-overuse-seen.
317
Information Plus. Nutrition: A Key to Good Health. Wylie, TX: Information Plus, 1999.
318
Naifeh S. W. The Best Doctors in America, 1994–1995. Aiken, SC: Woodward & White, 1994.
319
Esselstyn C. B., Jr. “Foreword: changing the treatment paradigm for coronary artery disease.” Am. J. Cardiol. 82 (1998): 2T–4T.
320
Esselstyn C. B., Ellis S. G., Medendorp S. V., et al. “A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician’s practice.” J. Family Practice 41 (1995): 560–568.
321
Esselstyn C. B., Ellis S. G., Medendorp S. V., et al. “A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician’s practice.” J. Family Practice 41 (1995): 560–568.
322
Esselstyn C. J. “Introduction: more than coronary artery disease.” Am. J. Cardiol. 82 (1998): 5T–9T.
323
Esselstyn C. B., Ellis S. G., Medendorp S. V., et al. “A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician’s practice.” J. Family Practice 41 (1995): 560–568.
324
Esselstyn C. B., Ellis S. G., Medendorp S. V., et al. “A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician’s practice.” J. Family Practice 41 (1995): 560–568.
325
Esselstyn C. J. “Introduction: more than coronary artery disease.” Am. J. Cardiol. 82 (1998): 5T–9T.
326
Esselstyn C. J. “Introduction: more than coronary artery disease.” Am. J. Cardiol. 82 (1998): 5T–9T.
327
Esselstyn C. B., Ellis S. G., Medendorp S. V., et al. “A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician’s practice.” J. Family Practice 41 (1995): 560–568.
328
Esselstyn C. J. “Introduction: more than coronary artery disease.” Am. J. Cardiol. 82 (1998): 5T–9T.
329
Esselstyn C. J. “Introduction: more than coronary artery disease.” Am. J. Cardiol. 82 (1998): 5T–9T.
330
Поток крови пропорционален четвертой степени радиуса. Таким образом, снижение на 7 % означает примерно 30 %-ное увеличение потока крови, хотя невозможно получить расчетным путем более точное определение этого показателя.
331
Esselstyn C. B., Ellis S. G., Medendorp S. V., et al. “A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician’s practice.” J. Family Practice 41 (1995): 560–568.
332
Esselstyn C. J. “Resolving the coronary artery disease epidemic through plant-based nutrition.” Prev. Cardiol. 4 (2001): 171–177.
333
Esselstyn C. B., Ellis S. G., Medendorp S. V., et al. “A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician’s practice.” J. Family Practice 41 (1995): 560–568.
334
Личное общение с доктором Эссельстином 15 сентября 2003 г.
335
Esselstyn C. B. J., Gendy G., Doyle J., et al. “A way to reverse CAD?” J. Fam. Pract. 63 (2014): 356–364b; Esselstyn C., and Golubic M. “The nutritional reversal of cardiovascular disease, fact or fiction? Three case reports.” Exp. Clin. Cardiol. 20 (2014): 1901–1908.
336
«Вилки вместо ножей», режиссер Ли Фалкерсон / Fulkerson, Lee, director. Forks Over Knives. Monica Beach Media, 2011.
337
Ornish D., Brown S. E., Scherwitz L. W., et al. “Can lifestyle changes reverse coronary heart disease?” Lancet 336 (1990): 129–133.
338
Ornish D., Brown S. E., Scherwitz L. W., et al. “Can lifestyle changes reverse coronary heart disease?” Lancet 336 (1990): 129–133.
339
Ornish D., Brown S. E., Scherwitz L. W., et al. “Can lifestyle changes reverse coronary heart disease?” Lancet 336 (1990): 129–133.
340
Ornish D., Brown S. E., Scherwitz L. W., et al. “Can lifestyle changes reverse coronary heart disease?” Lancet 336 (1990): 129–133.
341
Ornish D. “Avoiding revascularization with lifestyle changes: the Multicenter Lifestyle Demonstration Project.” Am. J. Cardiol. 82 (1998): 72T–76T.
342
Ornish D. “Avoiding revascularization with lifestyle changes: the Multicenter Lifestyle Demonstration Project.” Am. J. Cardiol. 82 (1998): 72T–76T.
343
Ornish D. “Avoiding revascularization with lifestyle changes: the Multicenter Lifestyle Demonstration Project.” Am. J. Cardiol. 82 (1998): 72T–76T.
344
Национальный институт болезней сердца, легких и крови США / National Heart, Lung, and Blood Institute. “Morbidity and Mortality: 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases.” Bethesda, MD: National Institutes of Health, 2002.
345
Ornish D. “Avoiding revascularization with lifestyle changes: the Multicenter Lifestyle Demonstration Project.” Am. J. Cardiol. 82 (1998): 72T–76T.
346
Ornish D. “Avoiding revascularization with lifestyle changes: the Multicenter Lifestyle Demonstration Project.” Am. J. Cardiol. 82 (1998): 72T–76T.
347
DeFrances C. J., Licas C. A., Vuie V. C., and Golosinskiy A. “2006 National Hospital discharge survey.” Hyattsville, MD: National Center for Health Statistics, 2008.
348
Epstein A. J., Polsky D., Yang F., Yang L., and Groeneveld P. W. “Coronary revascularization trends in the United States, 2001–2008.” JAMA 305 (2011): 1769–1776.
349
Epstein A. J., Polsky D., Yang F., Yang L., and Groeneveld P. W. “Coronary revascularization trends in the United States, 2001–2008.” JAMA 305 (2011): 1769–1776.
350
Boyles S. “Heart bypass surgery rate is declining.” WebMD Health News (2011).
351
Wani M. “How much does a heart stent cost?” Buzzle (2013). На сайте www.buzzle.com/articles/how-much-does-a-heart-stent-cost.html “Heart stent cost.” CostHelperHealth. На сайте health.costhelper.com/stents.html.
352
Heart bypass surgery cost.” CostHelperHealth. На сайте health.costhelper.com/bypass.html.
353
Личное общение с доктором Эссельстином, 2014 г.
354
Cooper, R. “Statins: the drug firms’ goldmine.” Telegraph (19 января 2011 г.). На сайте www.telegraph.co.uk/news/health/news/8267876/Statins-the-drug-firms-goldmine.html.
355
Heidenreich P. A., et al. “Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.” Circulation 123 (2011): 933–944.
Читать дальшеИнтервал:
Закладка:
